Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular fluid volume replenishment refers to the physiological processes that restore the amount of fluid in the extracellular compartment after losses due to various causes such as sweating, bleeding, burns, diuresis, or disease states. The extracellular compartment includes interstitial fluid and plasma. Its maintenance depends primarily on two interrelated regulatory systems: 1. The control of total body water content mainly regulated by vasopressin which adjusts thirst sensation and renal water excretion. 2. Osmotic forces governed largely by sodium and chloride concentrations in the ECF that determine how much water shifts into this compartment from cells. Neurohumoral mechanisms including vasopressin secretion responding to plasma osmolality changes and RAAS activity modulating renal sodium handling work together dynamically. For example: - Vasopressin promotes free water retention when plasma becomes hypertonic. - RAAS activation increases sodium reabsorption leading to increased ECF volume. In clinical practice, restoring extracellular volume often involves administration of intravenous fluids tailored according to whether there has been loss predominantly of free water versus salt-containing fluids—hypotonic solutions for hypertonic contraction states versus isotonic saline for hypotonic contraction[1][3]. This concept is fundamental in understanding body-fluid homeostasis but does not represent an individual molecular entity suitable as a drug target per se[1][3].
Drugs targeting this process act by: - Modulating renal sodium reabsorption via RAAS pathways - Adjusting water retention through vasopressin-mediated mechanisms - Replenishing lost extracellular fluid volume with appropriate intravenous fluids based on tonicity
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular fluid volume replenishment.